BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37719099)

  • 1. Validation of prognosis-based in vitro fertilization grant selection criteria.
    Bakkensen JB; Heisler E; Bolten K; Yilmaz B; Smiley J; Hirshfeld-Cytron JE; Feinberg EC
    F S Rep; 2023 Sep; 4(3):286-291. PubMed ID: 37719099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative live birth rates in low-prognosis women.
    Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; van Golde RJT; Hoek A; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Torrance HL; Broekmans FJM;
    Hum Reprod; 2019 Jun; 34(6):1030-1041. PubMed ID: 31125412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative live birth rate after IVF: trend over time and the impact of blastocyst culture and vitrification.
    Saket Z; Källén K; Lundin K; Magnusson Å; Bergh C
    Hum Reprod Open; 2021; 2021(3):hoab021. PubMed ID: 34195386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the cumulative chance of live birth over multiple complete cycles of in vitro fertilization: an external validation study.
    Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; McLernon DJ; Bhattacharya S; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2018 Sep; 33(9):1684-1695. PubMed ID: 30085143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.
    Xu B; Geerts D; Hu S; Yue J; Li Z; Zhu G; Jin L
    Hum Reprod; 2020 Jun; 35(6):1306-1318. PubMed ID: 32478400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oocyte or embryo number needed to optimize live birth and cumulative live birth rates in mild stimulation IVF cycles.
    Datta AK; Campbell S; Felix N; Singh JSH; Nargund G
    Reprod Biomed Online; 2021 Aug; 43(2):223-232. PubMed ID: 34140227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometriosis and oocyte quality: an analysis of 13 614 donor oocyte recipient and autologous IVF cycles.
    Kamath MS; Subramanian V; Antonisamy B; Sunkara SK
    Hum Reprod Open; 2022; 2022(3):hoac025. PubMed ID: 35747401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential impact of controlled ovarian hyperstimulation on live birth rate in fresh versus frozen embryo transfer cycles: a Society for Assisted Reproductive Technology Clinic Outcome System study.
    Gerber RS; Fazzari M; Kappy M; Cohen A; Galperin S; Lieman H; Jindal S; Buyuk E
    Fertil Steril; 2020 Dec; 114(6):1225-1231. PubMed ID: 33012553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Serum LH Levels During Ovarian Stimulation With GnRH Antagonist Protocol Decrease the Live Birth Rate After Fresh Embryo Transfers but Have No Impact in Freeze-All Cycles.
    Luo Y; Liu S; Su H; Hua L; Ren H; Liu M; Wan Y; Li H; Li Y
    Front Endocrinol (Lausanne); 2021; 12():640047. PubMed ID: 33967956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Trigger for Final Follicular Maturation Improves Cumulative Live-Birth Rate in Ovarian Stimulation for Freeze-All
    Zhu H; Zhao C; Pan Y; Zhou H; Jin X; Xu W; Zhang S
    Front Endocrinol (Lausanne); 2021; 12():708247. PubMed ID: 34349729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probability of live birth after IVF/ICSI treatments in female early onset cancer survivors: a Finnish population-based registry study.
    Melin J; Tiitinen A; Hirvonen E; Malila N; Pitkäniemi J; Gissler M; Madanat-Harjuoja L
    Hum Reprod; 2021 Nov; 36(12):3131-3140. PubMed ID: 34491339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation.
    Cornelisse S; Zagers M; Kostova E; Fleischer K; van Wely M; Mastenbroek S
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD005291. PubMed ID: 32898291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifestyle intervention prior to IVF does not improve embryo utilization rate and cumulative live birth rate in women with obesity: a nested cohort study.
    Wang Z; Groen H; Van Zomeren KC; Cantineau AEP; Van Oers A; Van Montfoort APA; Kuchenbecker WKH; Pelinck MJ; Broekmans FJM; Klijn NF; Kaaijk EM; Mol BWJ; Hoek A; Van Echten-Arends J
    Hum Reprod Open; 2021; 2021(4):hoab032. PubMed ID: 34557597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate analysis of oocyte donor and recipient factors affecting cumulative live birth rate in oocyte donor IVF (OD-IVF) cycles.
    Malhotra N; Gupta M; Yadav A; Jaiswal P; Bansiwal R; Singh N; Upadhyay AD; Bhatt A; Mahey R
    JBRA Assist Reprod; 2021 Oct; 25(4):549-556. PubMed ID: 34338480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of comparative performance criteria for IVF centers: correlation of live birth rates in autologous and donor oocyte IVF cycles.
    Kushnir VA; Khanna P; Barad DH; Gleicher N
    Reprod Biol Endocrinol; 2014 Dec; 12():122. PubMed ID: 25475407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles.
    Law YJ; Zhang N; Venetis CA; Chambers GM; Harris K
    Hum Reprod; 2019 Sep; 34(9):1778-1787. PubMed ID: 31398253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China.
    Ji J; Liu Y; Tong XH; Luo L; Ma J; Chen Z
    Hum Reprod; 2013 Oct; 28(10):2728-34. PubMed ID: 23887075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles.
    Yang C; Dong N; Li F; Ji Y; Pan Y; She H
    J Ovarian Res; 2022 Jun; 15(1):74. PubMed ID: 35729654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.